PATENT CLAIM ANALYSIS

Application Number: 15756058
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["424", "204100"]

Abstract:
The present invention relates to a composition for intracellular delivery containing an adenovirus protein VI-derived peptide and an anti-cancer pharmaceutical composition containing the same. According to the present invention, the use of the peptide or peptide-polymer composite of the present invention improves intracellular delivery efficiency of a nucleic acid, a peptide, a poly-peptide, an antibody, a chemical material, or a virus. Therefore, the peptide or peptide-polymer composite of the present invention can be favorably used as an intracellular delivery system for various therapeutics.

Claim (Index 34):
The method of  claim 18 , wherein the cancer is breast cancer, non-small cell lung cancer, lung cancer, stomach cancer, liver cancer, blood cancer, bone cancer, pancreatic cancer, skin cancer, head and neck cancer, dermal or ocular melanoma, uterine sarcoma, ovarian cancer, rectal cancer, anal cancer, colorectal cancer, tubal cancer, endometrial cancer, uterine cervical cancer, small bowel neoplasm, endocrine carcinoma, bladder cancer, larynx cancer, osteosarcoma, thyroid cancer, brain cancer, colon cancer, vaginal cancer, vulvar cancer, Hodgkin's disease, esophageal cancer, adrenal gland cancer, penile carcinoma, acute leukemia, lymphocyte lymphoma, ureteral cancer, renal pelvic carcinoma, a central nervous system (CNS) tumor, primary CNS lymphoma, a spinal cord tumor, nasopharyngeal cancer, brain stem glioma, pituitary adenoma, parathyroid cancer, kidney cancer, soft tissue sarcoma, a urethral tumor, prostate cancer, bronchial cancer or bone marrow cancer.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 88.0
- Lexical Diversity: 1.97872
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15538975', '12557031', '10353522', '15313674', '10018103']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.745021087025181
- 35 USC 102 Novelty (BERT): 0.5046315893696416
- Combined Prediction Score: 0.7209821372596271
- Mean Citation Score: 249.94336000000004
- Max Citation Score: 258.81607
- Similarity Product: 184.2822592530323

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test